Cargando…

Outcome of surgery in locally advanced pT3a prostate cancer

INTRODUCTION: The aim of this study is to present the oncologic outcomes and to determine prognostic parameters of overall (OS), cancer specific survival (CSS), disease progression free survival (DPFS) and biochemical progression free survival (BPFS) after surgery for pT3a prostate cancer (PCa). MAT...

Descripción completa

Detalles Bibliográficos
Autores principales:	Milonas, Daimantas, Baltrimavicius, Ruslanas, Grybas, Aivaras, Gudinaviciene, Inga, Trumbeckas, Darius, Kincius, Marius, Auskalnis, Stasys, Jievaltas, Mindaugas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Polish Urological Association 2011
Materias:	Urological Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3921749/ https://www.ncbi.nlm.nih.gov/pubmed/24578895 http://dx.doi.org/10.5173/ceju.2011.04.art4

Ejemplares similares

Factors predicting Gleason score 6 upgrading after radical prostatectomy
por: Milonas, Daimantas, et al.
Publicado: (2011)

Independent predictors of biochemical recurrence after radical prostatectomy: a single center experience
por: Kinčius, Marius, et al.
Publicado: (2011)

Importance of prostate volume and urinary flow rate in prediction of bladder outlet obstruction in men with symptomatic benign prostatic hyperplasia
por: Trumbeckas, Darius, et al.
Publicado: (2011)

Impact of the 2014 International Society of Urological Pathology Grading System on Concept of High-Risk Prostate Cancer: Comparison of Long-Term Oncological Outcomes in Patients Undergoing Radical Prostatectomy
por: Milonas, Daimantas, et al.
Publicado: (2019)

Effect of Clinical Parameters on Risk of Death from Cancer after Radical Prostatectomy in Men with Localized and Locally Advanced Prostate Cancer
por: Milonas, Daimantas, et al.
Publicado: (2022)

Significance of Time Until PSA Recurrence After Radical Prostatectomy Without Neo- or Adjuvant Treatment to Clinical Progression and Cancer-Related Death in High-Risk Prostate Cancer Patients
por: Venclovas, Zilvinas, et al.
Publicado: (2019)

Long-Term Oncological Outcomes for Young Men Undergoing Radical Prostatectomy for Localized Prostate Cancer
por: Milonas, Daimantas, et al.
Publicado: (2017)

Age and aggressiveness of prostate cancer: analysis of clinical and pathological characteristics after radical prostatectomy for men with localized prostate cancer
por: Milonas, Daimantas, et al.
Publicado: (2019)

Head-to-Head Comparison of Two Nomograms Predicting Probability of Lymph Node Invasion in Prostate Cancer and the Therapeutic Impact of Higher Nomogram Threshold
por: Venclovas, Zilvinas, et al.
Publicado: (2021)

The effect of complete transurethral resection of the prostate on symptoms, quality of life, and voiding function improvement
por: Milonas, Daimantas, et al.
Publicado: (2015)

External validation of Memorial Sloan Kettering Cancer Center nomogram and prediction of optimal candidate for lymph node dissection in clinically localized prostate cancer
por: Milonas, Daimantas, et al.
Publicado: (2020)

Impact of Grade Groups on Prostate Cancer-Specific and Other-Cause Mortality: Competing Risk Analysis from a Large Single Institution Series
por: Milonas, Daimantas, et al.
Publicado: (2021)

Incidence, mortality and survival trends of penile cancer in Lithuania 1998–2017
por: Drevinskaite, Mingaile, et al.
Publicado: (2023)

Caffeic Acid Phenethyl Ester Reduces Ischemia-Induced Kidney Mitochondrial Injury in Rats
por: Trumbeckaite, Sonata, et al.
Publicado: (2017)

A Population-Based Analysis of Incidence, Mortality, and Survival in Testicular Cancer Patients in Lithuania
por: Drevinskaite, Mingaile, et al.
Publicado: (2019)

Prostatic Artery Embolization as a Treatment Option for Symptomatic Benign Prostatic Hyperplasia: Results from the Prospective Follow-Up Study in Lithuania
por: Jankauskas, Tautvydas, et al.
Publicado: (2023)

Efficacy of Degarelix in the Neoadjuvant Setting in Managing Locally Advanced Prostate Cancer
por: Sankaran, Sindhu, et al.
Publicado: (2023)

Focal Cryoablation of the Prostate: Primary Treatment in 163 Patients With Localized Prostate Cancer
por: Khan, Anwar, et al.
Publicado: (2023)

Radical exenteration surgery is curative in locally advance mucinous prostatic adenocarcinoma involving bladder and rectum
por: Koo, Vincent S W, et al.
Publicado: (2010)

Characterization of Google Search Volumes and Trends From 2004 to 2021 for Diagnosis and Treatment of Locally Advanced Prostate Cancer
por: Kim, Jessica, et al.
Publicado: (2023)

Patient‐reported outcomes in the ProtecT randomized trial of clinically localized prostate cancer treatments: study design, and baseline urinary, bowel and sexual function and quality of life
por: Lane, Athene, et al.
Publicado: (2016)

Resveratrol in prostate diseases
por: Salagierski, Maciej
Publicado: (2013)

Inflammatory changes and the prostate
por: Soloway, Mark S.
Publicado: (2013)

United in Fight against prOstate cancer (UFO) registry: first results from a large, multi‐centre, prospective, longitudinal cohort study of advanced prostate cancer in Asia
por: Uemura, Hirotsugu, et al.
Publicado: (2020)

Obesity and prostate cancer research
por: Van den Broeck, Thomas, et al.
Publicado: (2013)

Best practice in active surveillance for men with prostate cancer: a Prostate Cancer UK consensus statement
por: Merriel, Samuel W.D., et al.
Publicado: (2019)

Thrombospondin 1 and cathepsin D improve prostate cancer diagnosis by avoiding potentially unnecessary prostate biopsies
por: Steuber, Thomas, et al.
Publicado: (2018)

Outpatient transperineal prostate biopsy under local anaesthesia is safe, well tolerated and feasible
por: Hong, Anne, et al.
Publicado: (2022)

Prostate cancer upgrading with serial prostate magnetic resonance imaging and repeat biopsy in men on active surveillance: are confirmatory biopsies still necessary?
por: Osses, Daniël F., et al.
Publicado: (2020)

Education concerning carcinoma of prostate and its early detection
por: Dutkiewcz, Sławomir, et al.
Publicado: (2011)

Prostate cancer recurrence – new prognostic factors are needed
por: Wajsman, Zew
Publicado: (2013)

Androgen deprivation therapy for prostate cancer and risk of dementia
por: Robinson, David, et al.
Publicado: (2019)

β-catenin as a prognostic factor for prostate cancer (PCa)
por: Nowicki, Andrzej, et al.
Publicado: (2012)

Complication rates after prostate biopsy according to the number of sampled cores
por: Madej, Adam, et al.
Publicado: (2012)

Predicting biochemical recurrence and prostate cancer‐specific mortality after radical prostatectomy: comparison of six prediction models in a cohort of patients with screening‐ and clinically detected prostate cancer
por: Remmers, Sebastiaan, et al.
Publicado: (2019)

Active surveillance for low-risk prostate cancer: well established, yet avoided?
por: Sosnowski, Roman, et al.
Publicado: (2022)

Impact of Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography on the Therapeutic Decision of Prostate Carcinoma Primary Staging: A Retrospective Analysis at the Brazilian National Public Health System
por: da Silva, Anna Carolina Borges, et al.
Publicado: (2023)

A four‐group urine risk classifier for predicting outcomes in patients with prostate cancer
por: Connell, Shea P., et al.
Publicado: (2019)

Distribution of prostate cancer recurrences on gallium‐68 prostate‐specific membrane antigen ((68)Ga‐PSMA) positron‐emission/computed tomography after radical prostatectomy with pathological node‐positive extended lymph node dissection
por: Huits, Thijs H., et al.
Publicado: (2020)

Psychosocial impact of undergoing prostate cancer screening for men with BRCA1 or BRCA2 mutations
por: Bancroft, Elizabeth K., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_7534va14g39gke0qbu2n1dp3pn